Universal Health Servs Analyst Ratings
Universal Health Servs Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
07/27/2023 | 19.49% | Credit Suisse | $163 → $169 | Maintains | Outperform |
07/26/2023 | 9.59% | Stephens & Co. | → $155 | Reiterates | Equal-Weight → Equal-Weight |
07/11/2023 | 20.2% | Mizuho | $150 → $170 | Maintains | Buy |
06/02/2023 | 15.25% | B of A Securities | → $163 | Assumes | Neutral → Buy |
05/16/2023 | -1.72% | Goldman Sachs | $124 → $139 | Maintains | Sell |
05/16/2023 | 6.06% | Mizuho | $140 → $150 | Maintains | Buy |
05/08/2023 | 8.89% | TD Cowen | $138 → $154 | Maintains | Market Perform |
04/27/2023 | 16.67% | Citigroup | $150 → $165 | Maintains | Buy |
04/27/2023 | 2.52% | Stephens & Co. | $140 → $145 | Maintains | Equal-Weight |
04/27/2023 | 9.59% | Deutsche Bank | $145 → $155 | Maintains | Buy |
04/27/2023 | 7.47% | RBC Capital | $130 → $152 | Maintains | Sector Perform |
04/27/2023 | 15.25% | Credit Suisse | $153 → $163 | Maintains | Outperform |
04/25/2023 | 0.4% | Barclays | $132 → $142 | Upgrades | Underweight → Equal-Weight |
04/21/2023 | 1.11% | Cantor Fitzgerald | → $143 | Initiates Coverage On | → Underweight |
04/19/2023 | -5.96% | JP Morgan | → $133 | Initiates Coverage On | → Neutral |
03/06/2023 | 2.52% | Deutsche Bank | $168 → $145 | Maintains | Buy |
03/06/2023 | -1.01% | Mizuho | $144 → $140 | Maintains | Buy |
03/06/2023 | -2.43% | Wells Fargo | $154 → $138 | Maintains | Equal-Weight |
03/03/2023 | 8.18% | Credit Suisse | $157 → $153 | Maintains | Outperform |
03/01/2023 | -8.08% | RBC Capital | $114 → $130 | Maintains | Sector Perform |
03/01/2023 | -1.01% | Stephens & Co. | $155 → $140 | Maintains | Equal-Weight |
03/01/2023 | — | Wolfe Research | Downgrades | Outperform → Peer Perform | |
02/28/2023 | 9.59% | Stephens & Co. | → $155 | Reiterates | → Equal-Weight |
01/24/2023 | 18.08% | UBS | $113 → $167 | Upgrades | Sell → Neutral |
01/09/2023 | -6.67% | Barclays | $115 → $132 | Maintains | Underweight |
01/03/2023 | 8.89% | Wells Fargo | → $154 | Upgrades | Underweight → Equal-Weight |
12/16/2022 | 2.52% | B of A Securities | $120 → $145 | Upgrades | Underperform → Neutral |
12/14/2022 | 1.82% | Mizuho | $126 → $144 | Maintains | Buy |
11/25/2022 | 11.01% | Credit Suisse | $129 → $157 | Maintains | Outperform |
11/02/2022 | -10.91% | Mizuho | $121 → $126 | Maintains | Buy |
10/27/2022 | -19.39% | SVB Leerink | $98 → $114 | Maintains | Market Perform |
08/24/2022 | -18.69% | SVB Leerink | $111 → $115 | Maintains | Market Perform |
07/28/2022 | -21.52% | SVB Leerink | $103 → $111 | Maintains | Market Perform |
07/27/2022 | -19.39% | RBC Capital | $130 → $114 | Maintains | Sector Perform |
07/15/2022 | -27.17% | SVB Leerink | $108 → $103 | Maintains | Market Perform |
07/12/2022 | -22.22% | Goldman Sachs | $125 → $110 | Maintains | Sell |
07/06/2022 | -36.36% | BMO Capital | → $90 | Downgrades | Market Perform → Underperform |
07/01/2022 | -0.3% | Credit Suisse | $156 → $141 | Maintains | Outperform |
07/01/2022 | -14.45% | Mizuho | $153 → $121 | Maintains | Buy |
06/30/2022 | -23.64% | SVB Leerink | $132 → $108 | Maintains | Market Perform |
06/17/2022 | -18.69% | Loop Capital | → $115 | Initiates Coverage On | → Hold |
05/13/2022 | -6.67% | SVB Leerink | $139 → $132 | Maintains | Market Perform |
05/03/2022 | 8.18% | Mizuho | $164 → $153 | Maintains | Buy |
04/28/2022 | -16.57% | Wells Fargo | $139 → $118 | Maintains | Underweight |
04/27/2022 | -4.55% | Stephens & Co. | $150 → $135 | Maintains | Equal-Weight |
04/27/2022 | 11.72% | Credit Suisse | $172 → $158 | Maintains | Outperform |
04/27/2022 | -8.08% | RBC Capital | $149 → $130 | Maintains | Sector Perform |
03/29/2022 | -1.72% | Wells Fargo | → $139 | Initiates Coverage On | → Underweight |
03/07/2022 | -5.25% | UBS | $124 → $134 | Maintains | Sell |
03/03/2022 | 15.96% | Mizuho | $151 → $164 | Maintains | Buy |
02/28/2022 | — | Seaport Global | Downgrades | Buy → Neutral | |
02/28/2022 | -1.72% | SVB Leerink | $136 → $139 | Maintains | Market Perform |
01/07/2022 | -3.84% | SVB Leerink | $132 → $136 | Maintains | Market Perform |
12/21/2021 | -0.3% | Barclays | $160 → $141 | Maintains | Underweight |
10/29/2021 | 6.77% | Mizuho | $178 → $151 | Maintains | Buy |
10/27/2021 | -6.67% | SVB Leerink | $140 → $132 | Maintains | Market Perform |
09/27/2021 | -1.01% | SVB Leerink | → $140 | Initiates Coverage On | → Market Perform |
09/24/2021 | -3.84% | UBS | → $136 | Initiates Coverage On | → Sell |
09/08/2021 | 6.06% | Goldman Sachs | $155 → $150 | Downgrades | Neutral → Sell |
08/12/2021 | 10.3% | Barclays | $170 → $156 | Downgrades | Overweight → Underweight |
07/28/2021 | 30.81% | Deutsche Bank | $160 → $185 | Maintains | Buy |
07/27/2021 | 20.2% | Barclays | $160 → $170 | Maintains | Overweight |
07/09/2021 | 20.2% | Seaport Global | → $170 | Initiates Coverage On | → Buy |
06/10/2021 | 16.67% | RBC Capital | $160 → $165 | Downgrades | Outperform → Sector Perform |
04/28/2021 | 13.13% | RBC Capital | $150 → $160 | Maintains | Outperform |
04/19/2021 | 13.13% | Deutsche Bank | $145 → $160 | Maintains | Buy |
01/05/2021 | 1.82% | B of A Securities | → $144 | Downgrades | Neutral → Underperform |
09/21/2020 | -18.69% | JP Morgan | $138 → $115 | Downgrades | Neutral → Underweight |
07/29/2020 | -17.27% | Piper Sandler | $113 → $117 | Maintains | Neutral |
07/29/2020 | -1.01% | Credit Suisse | $139 → $140 | Maintains | Outperform |
06/09/2020 | -2.43% | Barclays | → $138 | Upgrades | Equal-Weight → Overweight |
04/30/2020 | -5.96% | UBS | $150 → $133 | Maintains | Buy |
04/29/2020 | -4.55% | Deutsche Bank | $165 → $135 | Maintains | Buy |
04/28/2020 | -9.5% | Citigroup | $157 → $128 | Maintains | Buy |
04/23/2020 | -20.1% | Piper Sandler | $141 → $113 | Maintains | Neutral |
03/23/2020 | — | B of A Securities | Downgrades | Buy → Neutral | |
03/02/2020 | 9.59% | JP Morgan | $164 → $155 | Maintains | Neutral |
02/28/2020 | 16.67% | Baird | $160 → $165 | Maintains | Outperform |
02/28/2020 | 6.06% | UBS | $158 → $150 | Maintains | Buy |
02/28/2020 | 6.77% | Stephens & Co. | $153 → $151 | Maintains | Equal-Weight |
12/20/2019 | 15.96% | JP Morgan | $159 → $164 | Maintains | Neutral |
10/28/2019 | -2.43% | Barclays | $145 → $138 | Maintains | Equal-Weight |
07/31/2019 | 3.23% | Morgan Stanley | $135 → $146 | Maintains | Equal-Weight |
04/17/2019 | -8.08% | Barclays | $136 → $130 | Maintains | Equal-Weight |
03/04/2019 | 13.84% | UBS | $156 → $161 | Maintains | Buy |
03/04/2019 | — | JP Morgan | Downgrades | Overweight → Neutral | |
03/01/2019 | 13.13% | Deutsche Bank | $140 → $160 | Maintains | Buy |
03/01/2019 | -3.84% | Barclays | $130 → $136 | Maintains | Equal-Weight |
03/01/2019 | 6.06% | Wells Fargo | $147 → $150 | Maintains | Outperform |
03/01/2019 | 15.96% | Citigroup | $140 → $164 | Maintains | Buy |
02/28/2019 | 2.52% | Baird | $140 → $145 | Maintains | Outperform |
01/14/2019 | — | Stephens & Co. | Initiates Coverage On | → Equal-Weight | |
01/03/2019 | -1.01% | Deutsche Bank | → $140 | Initiates Coverage On | → Buy |
12/14/2018 | — | Goldman Sachs | Downgrades | Neutral → Sell | |
10/29/2018 | -8.08% | Morgan Stanley | $134 → $130 | Maintains | Equal-Weight |
10/29/2018 | -8.08% | Barclays | $135 → $130 | Maintains | Equal-Weight |
10/29/2018 | -1.01% | Citigroup | $145 → $140 | Maintains | Buy |
09/18/2018 | 9.59% | B of A Securities | $128 → $155 | Upgrades | Neutral → Buy |
09/05/2018 | -5.25% | Morgan Stanley | $122 → $134 | Maintains | Equal-Weight |
08/14/2018 | -4.55% | Barclays | → $135 | Initiates Coverage On | → Equal-Weight |
08/01/2018 | — | BMO Capital | Downgrades | Outperform → Market Perform | |
07/27/2018 | -13.74% | Morgan Stanley | $120 → $122 | Maintains | Equal-Weight |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
07/27/2023 | 19.49% | 瑞士信貸 | $163→$169 | 維護 | 跑贏大盤 |
07/26/2023 | 9.59% | 斯蒂芬斯公司 | →$155 | 重申 | 等重→等重 |
07/11/2023 | 20.2% | 瑞穗 | $150→$170 | 維護 | 買 |
06/02/2023 | 15.25% | B of A證券 | →$163 | 假設 | 中性→購買 |
2023年05月16日 | -1.72% | 高盛 | $124→$139 | 維護 | 賣 |
2023年05月16日 | 6.06% | 瑞穗 | $140→$150 | 維護 | 買 |
05/08/2023 | 8.89% | TD Cowen | $138→$154 | 維護 | 市場表現 |
04/27/2023 | 16.67% | 花旗集團 | $150→$165 | 維護 | 買 |
04/27/2023 | 2.52% | 斯蒂芬斯公司 | $140→$145 | 維護 | 等重 |
04/27/2023 | 9.59% | 德意志銀行 | $145→$155 | 維護 | 買 |
04/27/2023 | 7.47% | 加拿大皇家銀行資本 | $130→$152 | 維護 | 行業表現 |
04/27/2023 | 15.25% | 瑞士信貸 | $153→$163 | 維護 | 跑贏大盤 |
04/25/2023 | 百分之零點四 | 巴克萊 | $132→$142 | 升級 | 重量不足的→等重 |
04/21/2023 | 1.11% | 康託·菲茨傑拉德 | →$143 | 開始承保 | →減持 |
04/19/2023 | -5.96% | 摩根大通 | →$133 | 開始承保 | →中性 |
03/06/2023 | 2.52% | 德意志銀行 | $168→$145 | 維護 | 買 |
03/06/2023 | -1.01% | 瑞穗 | $144→$140 | 維護 | 買 |
03/06/2023 | -2.43% | 富國銀行 | $154→$138 | 維護 | 等重 |
03/03/2023 | 8.18% | 瑞士信貸 | $157→$153 | 維護 | 跑贏大盤 |
03/01/2023 | -8.08% | 加拿大皇家銀行資本 | $114→$130 | 維護 | 行業表現 |
03/01/2023 | -1.01% | 斯蒂芬斯公司 | $155→$140 | 維護 | 等重 |
03/01/2023 | - | 沃爾夫研究 | 評級下調 | 超越→同行的表現 | |
02/28/2023 | 9.59% | 斯蒂芬斯公司 | →$155 | 重申 | →等重 |
01/24/2023 | 18.08% | 瑞銀集團 | $113→$167 | 升級 | 賣出→中性 |
01/09/2023 | -6.67% | 巴克萊 | $115→$132 | 維護 | 體重不足 |
01/03/2023 | 8.89% | 富國銀行 | →$154 | 升級 | 重量不足的→等重 |
12/16/2022 | 2.52% | B of A證券 | $120→$145 | 升級 | 表現不佳的→中性 |
2022年12月14日 | 1.82% | 瑞穗 | $126→$144 | 維護 | 買 |
2022年11月25日 | 11.01% | 瑞士信貸 | $129→$157 | 維護 | 跑贏大盤 |
11/02/2022 | -10.91% | 瑞穗 | $121→$126 | 維護 | 買 |
10/27/2022 | -19.39% | SVB Leerink | $98→$114 | 維護 | 市場表現 |
2022年08月24日 | -18.69% | SVB Leerink | $111→$115 | 維護 | 市場表現 |
07/28/2022 | -21.52% | SVB Leerink | $103→$111 | 維護 | 市場表現 |
07/27/2022 | -19.39% | 加拿大皇家銀行資本 | $130→$114 | 維護 | 行業表現 |
07/15/2022 | -27.17% | SVB Leerink | $108→$103 | 維護 | 市場表現 |
07/12/2022 | -22.22% | 高盛 | $125→$110 | 維護 | 賣 |
07/06/2022 | -36.36% | 蒙特利爾銀行資本 | →$90 | 評級下調 | 市場表現→表現不佳 |
07/01/2022 | -0.3% | 瑞士信貸 | $156→$141 | 維護 | 跑贏大盤 |
07/01/2022 | -14.45% | 瑞穗 | $153→$121 | 維護 | 買 |
2022/06/30 | -23.64% | SVB Leerink | $132→$108 | 維護 | 市場表現 |
06/17/2022 | -18.69% | 環路資本 | →$115 | 開始承保 | →保留 |
2022年05月13日 | -6.67% | SVB Leerink | $139→$132 | 維護 | 市場表現 |
05/03/2022 | 8.18% | 瑞穗 | $164→$153 | 維護 | 買 |
04/28/2022 | -16.57% | 富國銀行 | $139→$118 | 維護 | 體重不足 |
04/27/2022 | -4.55% | 斯蒂芬斯公司 | $150→$135 | 維護 | 等重 |
04/27/2022 | 11.72% | 瑞士信貸 | $172→$158 | 維護 | 跑贏大盤 |
04/27/2022 | -8.08% | 加拿大皇家銀行資本 | $149→$130 | 維護 | 行業表現 |
03/29/2022 | -1.72% | 富國銀行 | →$139 | 開始承保 | →減持 |
03/07/2022 | -5.25% | 瑞銀集團 | $124→$134 | 維護 | 賣 |
03/03/2022 | 15.96% | 瑞穗 | $151→$164 | 維護 | 買 |
02/28/2022 | - | 環球海港 | 評級下調 | 購買→中性 | |
02/28/2022 | -1.72% | SVB Leerink | $136→$139 | 維護 | 市場表現 |
01/07/2022 | -3.84% | SVB Leerink | $132→$136 | 維護 | 市場表現 |
2021/12/21 | -0.3% | 巴克萊 | $160→$141 | 維護 | 體重不足 |
10/29/2021 | 6.77% | 瑞穗 | $178→$151 | 維護 | 買 |
10/27/2021 | -6.67% | SVB Leerink | $140→$132 | 維護 | 市場表現 |
09/27/2021 | -1.01% | SVB Leerink | →$140 | 開始承保 | →市場表現 |
09/24/2021 | -3.84% | 瑞銀集團 | →$136 | 開始承保 | →銷售 |
09/08/2021 | 6.06% | 高盛 | $155→$150 | 評級下調 | 中性→銷售 |
2021/08/12 | 10.3% | 巴克萊 | $170→$156 | 評級下調 | 增持→減持 |
07/28/2021 | 30.81% | 德意志銀行 | $160→$185 | 維護 | 買 |
07/27/2021 | 20.2% | 巴克萊 | $160→$170 | 維護 | 超重 |
07/09/2021 | 20.2% | 環球海港 | →$170 | 開始承保 | →購買 |
2021/10/06 | 16.67% | 加拿大皇家銀行資本 | $160→$165 | 評級下調 | 跑贏→板塊表現 |
04/28/2021 | 13.13% | 加拿大皇家銀行資本 | $150→$160 | 維護 | 跑贏大盤 |
04/19/2021 | 13.13% | 德意志銀行 | $145→$160 | 維護 | 買 |
01/05/2021 | 1.82% | B of A證券 | →$144 | 評級下調 | 中性→表現不佳 |
2020/09/21 | -18.69% | 摩根大通 | $138→$115 | 評級下調 | 中性→減持 |
07/29/2020 | -17.27% | 派珀·桑德勒 | $113→$117 | 維護 | 中性 |
07/29/2020 | -1.01% | 瑞士信貸 | $139→$140 | 維護 | 跑贏大盤 |
06/09/2020 | -2.43% | 巴克萊 | →$138 | 升級 | 等重→超重 |
04/30/2020 | -5.96% | 瑞銀集團 | $150→$133 | 維護 | 買 |
04/29/2020 | -4.55% | 德意志銀行 | $165→$135 | 維護 | 買 |
04/28/2020 | -9.5% | 花旗集團 | $157→$128 | 維護 | 買 |
04/23/2020 | -20.1% | 派珀·桑德勒 | $141→$113 | 維護 | 中性 |
03/23/2020 | - | B of A證券 | 評級下調 | 購買→中性 | |
03/02/2020 | 9.59% | 摩根大通 | $164→$155 | 維護 | 中性 |
02/28/2020 | 16.67% | 貝爾德 | $160→$165 | 維護 | 跑贏大盤 |
02/28/2020 | 6.06% | 瑞銀集團 | $158→$150 | 維護 | 買 |
02/28/2020 | 6.77% | 斯蒂芬斯公司 | $153→$151 | 維護 | 等重 |
2019年12月20日 | 15.96% | 摩根大通 | $159→$164 | 維護 | 中性 |
2019年10月28日 | -2.43% | 巴克萊 | $145→$138 | 維護 | 等重 |
2019年07月31日 | 3.23% | 摩根士丹利 | $135→$146 | 維護 | 等重 |
2019/04/17 | -8.08% | 巴克萊 | $136→$130 | 維護 | 等重 |
2019/03/04 | 13.84% | 瑞銀集團 | $156→$161 | 維護 | 買 |
2019/03/04 | - | 摩根大通 | 評級下調 | 超重→中性 | |
2019年03月01日 | 13.13% | 德意志銀行 | $140→$160 | 維護 | 買 |
2019年03月01日 | -3.84% | 巴克萊 | $130→$136 | 維護 | 等重 |
2019年03月01日 | 6.06% | 富國銀行 | $147→$150 | 維護 | 跑贏大盤 |
2019年03月01日 | 15.96% | 花旗集團 | $140→$164 | 維護 | 買 |
2019年02月28日 | 2.52% | 貝爾德 | $140→$145 | 維護 | 跑贏大盤 |
2019年01月14日 | - | 斯蒂芬斯公司 | 開始承保 | →等重 | |
2019年03月01日 | -1.01% | 德意志銀行 | →$140 | 開始承保 | →購買 |
2018年12月14日 | - | 高盛 | 評級下調 | 中性→銷售 | |
2018年10月29日 | -8.08% | 摩根士丹利 | $134→$130 | 維護 | 等重 |
2018年10月29日 | -8.08% | 巴克萊 | $135→$130 | 維護 | 等重 |
2018年10月29日 | -1.01% | 花旗集團 | $145→$140 | 維護 | 買 |
2018年09月18日 | 9.59% | B of A證券 | $128→$155 | 升級 | 中性→購買 |
2018年09月05日 | -5.25% | 摩根士丹利 | $122→$134 | 維護 | 等重 |
2018年08月14日 | -4.55% | 巴克萊 | →$135 | 開始承保 | →等重 |
2018年08月01日 | - | 蒙特利爾銀行資本 | 評級下調 | 跑贏→市場表現 | |
2018年07月27日 | -13.74% | 摩根士丹利 | $120→$122 | 維護 | 等重 |
What is the target price for Universal Health Servs (UHS)?
Universal Health Serv(UHS)的目標價格是多少?
The latest price target for Universal Health Servs (NYSE: UHS) was reported by Credit Suisse on July 27, 2023. The analyst firm set a price target for $169.00 expecting UHS to rise to within 12 months (a possible 19.49% upside). 33 analyst firms have reported ratings in the last year.
瑞士信貸於2023年7月27日報告了Universal Health Serv(紐約證券交易所代碼:UHS)的最新目標價。這家分析公司將目標價定為169.00美元,預計UHS將在12個月內上漲至19.49%。33家分析公司在過去一年中公佈了評級。
What is the most recent analyst rating for Universal Health Servs (UHS)?
分析師對Universal Health Serv(UHS)的最新評級是多少?
The latest analyst rating for Universal Health Servs (NYSE: UHS) was provided by Credit Suisse, and Universal Health Servs maintained their outperform rating.
環球健康服務公司(紐約證券交易所代碼:UHS)的最新分析師評級由瑞士信貸提供,環球健康服務公司維持其表現優於大盤的評級。
When is the next analyst rating going to be posted or updated for Universal Health Servs (UHS)?
Universal Health Serv(UHS)的下一次分析師評級將於何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Universal Health Servs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Universal Health Servs was filed on July 27, 2023 so you should expect the next rating to be made available sometime around July 27, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與Universal Health Serv的高管和客戶交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Universal Health Serv的上一次評級是在2023年7月27日提交的,因此您應該預計下一次評級將在2024年7月27日左右提供。
Is the Analyst Rating Universal Health Servs (UHS) correct?
分析師對Universal Health Serv(UHS)的評級正確嗎?
While ratings are subjective and will change, the latest Universal Health Servs (UHS) rating was a maintained with a price target of $163.00 to $169.00. The current price Universal Health Servs (UHS) is trading at is $141.43, which is out of the analyst's predicted range.
雖然評級是主觀的,並將發生變化,但最新的Universal Health Serv(UHS)評級保持不變,目標價在163.00美元至169.00美元之間。Universal Health Serv目前的交易價格為141.43美元,超出了分析師的預測範圍。